by AIP Online Bureau | Jan 4, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic
BENGALURU: A top executive at an Indian biotechnology company defended its COVID-19 vaccine candidate, approved for emergency use by the government, and said it will produce efficacy data from late-stage trials by March.The vaccine, COVAXIN, received emergency...
by AIP Online Bureau | Jan 4, 2021 | Eco/Invest/Demography, Indian News, Reinsurance
Hydearbad: The insurance regulator IRDAI, for the Indian general insurance industry, has retained the system of 5 per cent obligatory cession with the GIC Re in Fy 2021-22. “The percentage cession of the sum insured on each general...
by AIP Online Bureau | Jan 4, 2021 | Indian News, Non-Life
New Delhi: Anjan Dey,57,director & general manager, GIC Re, on Monday, has been selected as the CMD of Delhi based Oriental Insurance Company(OIC) by the Banks Board Bureau (BBB),the official head hunting body for selecting the CEOs of state...
by AIP Online Bureau | Jan 4, 2021 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic
NEW DELHI l India will not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the head of Serum Institute of India, which has been contracted to make 1 billion doses of the vaccine for developing nations, said Sunday....
by AIP Online Bureau | Jan 4, 2021 | Eco/Invest/Demography, Facts, Health, Non-Life, Pandemic
SEOUL: When Ryu Han-na, a 20-year-old university student, got cosmetic surgery on her nose in mid-December, she had a simple reason: it might be the last chance to do so covertly before people start taking off masks this year as vaccines are distributed.Ryu,...
